Correction: Systemic delivery of recombinant brain derived neurotrophic factor (BDNF) in the R6/2 mouse model of Huntington's disease (PLoS ONE (2013) 8: 5 (e64037) DOI: 10.1371/journal.pone.0064037);Systemic Delivery of Recombinant Brain Derived Neurotrophic Factor (BDNF) in the R6/2 Mouse Model of Huntington's Disease

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Giampà, Carmela ^a   Montagna, Elena ^a   Dato, Clemente ^a   Melone, Mariarosa A B ^c,d   Bernardi, Giorgio ^a,b   Fusco, Francesca Romana ^a  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

^d INSTITUTE OF PROTEIN BIOCHEMISTRY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; MESSENGER RNA; RECOMBINANT BRAIN DERIVED NEUROTROPHIC FACTOR;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; CELL NUCLEUS INCLUSION BODY; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; GENE EXPRESSION; HUNTINGTON CHOREA; IMMUNOHISTOCHEMISTRY; LOCOMOTION; MALE; MICROGLIA; MOUSE; NEUROPROTECTION; NONHUMAN; OPEN FIELD TEST; OSMOTIC MINIPUMP; OUTCOME ASSESSMENT; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ROTAROD TEST; TASK PERFORMANCE; WESTERN BLOTTING;

EID: 84877905808     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0166102     Document Type: Erratum

References (58)

1. Wilson RS, Como PG, Garron DC, Klawans HL, Barr A, et al. (1987) Memory failure in Huntington's disease. J Clin Exp Neuropsychol 9: 147-154.
2. Vonsattel JP, Gusella JF, Hersch S, Auerbach W, Joyner AL, et al. (2000) Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice. Hum Mol Genet 9: 503-513.
3. De La Monte SM, Vonsattel JP, Richardson EP Jr, (1988) Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington's disease. J Neuropathol Exp Neurol 47: 516-525.
4. Albin RL, Tagle DA, (1995) Genetics and molecular biology of Huntington's disease. Trends Neurosci18: 11-14.
5. The Huntington's disease collaborative research group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell 72: 971-983.
6. DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, et al. (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277: 1990-1993.
7. Sugars KL, Rubinsztein DC, (2003) Transcriptional abnormalities in Huntington disease. Trends Genet 19: 233-238.
8. Auer RN, Olsson Y, Siesjö BK, (1984) Hypoglycemic brain injury in the rat. Correlation of density of brain damage with the EEG isoelectric time: a quantitative study. Diabetes. 33(11): 1090-8.
9. Smith ML, Auer RN, Siesjö BK, (1984) The density and distribution of ischemic brain injury in the rat following 2-10 min of forebrain ischemia. Acta Neuropathol. 64(4): 319-32.
10. Figueredo-Cardenas G, Chen Q, Reiner A, (1997) Age-dependent differ- ences in survival of striatal somatostatin-NPY-NADPH-diaphorase-containing interneurons versus striatal projection neurons after intrastriatal injection of quinolinic acid in rats. Exp. Neurol. 156 (2): 444-457.
11. Zuccato C, Cattaneo E, (2007) Role of brain-derived neurotrophic factor in Huntington's disease. Prog Neurobiol 81: 294-330.
12. Altar CA, Cai N, Bliven T, Juhasz M, Conner JM, et al. (1997) Anterograde transport of brain-derived neurotrophic factor and its role in the brain. Nature389: 856-860.
13. Conner JM, Lauterborn JC, Yan Q, Gall CM, Varon S, (1997) Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport. J Neurosci17: 2295-2313.
14. Salin T, Mudo G, Jiang XH, Timmusk T, Metsis M, et al. (1995) Up-regulation of trkB mRNA expression in the rat striatum after seizures. Neurosci. Lett., 181-184.
15. Zuccato C, Tartari M, Crotti A, Goffredo D, Valenza M, et al. (2003) Huntingtin interacts with REST/NRSF to mod- ulate the transcription of NRSE-controlled neuronal genes. Nat Genet 35: 76-83.
16. Perez-Navarro E, Canudas AM, Akerund P, Alberch J, Arenas E (2000) Brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin 4/5 prevent the death of striatal projection neurons in a rodent model of Huntington's disease. J. Neurochem., 75, 2190-2199.
17. Zuccato C, Ciammola A, Rigamonti D, Leavitt BR, Goffredo D, et al. (2001) Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease. Science 293: 493-498.
18. Ferrer I, Goutan E, Marín C, Rey MJ, Ribalta T (2000) Brain-derived neurotrophic factor in Huntington disease. Brain Res. 866 (1-2), 257-261.
19. Duan W, Guo Z, Jiang H, Ware M, Li XJ, et al. (2003) Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice. Proc Natl Acad Sci U S A. 100(5): 2911-6.
20. Zhang Y, Li M, Drozda M, Chen M, Ren S, et al. (2003) Depletion of wild-type huntingtin in mouse models of neurologic diseases. J Neurochem. 87(1): 101-6.
21. Gharami K, Xie Y, Ji An J, Tonegawa S, Xu B, (2008) Brain-derived Neurotrophic Factor Over-expression in the Forebrain Ameliorates Huntington's Disease Phenotypes in Mice J Neurochem. 105(2): 369-379.
22. Canals JM, Pineda JR, Torres-Peraza JF, Bosch M, Martín-Ibañez R, et al. (2004) Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease J Neurosci. Sep 1 24(35): 7727-39.
23. Nakao N, Brundin P, Funa K, Lindvall O, Odin P (1995) Trophic and protective actions of brain-derived neurotrophic factor on striatal DARPP-32-containing neurons in vitro DevelopmentalBrain Research 90 92-101.
24. Petersen A, Larsen KE, Behr GG, Romero N, Przedborski S, et al. (2001) Brain-derived neurotrophic factor inhibits apoptosis and dopamine-induced free radical production in striatal neurons but does not prevent cell death Brain Research Bulletin, Vol. 56, Nos. 3/4, 331-335.
25. Ciammola A, Sassone J, Cannella M, Calza S, Poletti B, et al. (2007) Low brain-derived neurotrophic factor (BDNF) levels in serum of Huntington's disease patients. Am J Med Genet B Neuropsychiatr Genet. Jun 5 144B(4): 574-7.
26. Beck T, Lindholm D, Castren E, Wree A, (1994) Brain-derived neurotrophic factor protects against ischemic cell damage in rat hippocampus. J Cereb Blood Flow Metab. 14: 689-692.
27. Zafra F, Hengerer B, Leibrock J, Thoenen H, Lindholm D, (1990) Activity dependent regulation of BDNF and NGF mRNAs in the rat hippocampus is mediated by non-NMDA glutamate receptors. Embo J9: 3545-3550.
28. Zafra F, Lindholm D, Castren E, Hartikka J, Thoenen H, (1992) Regulation of brain-derived neurotrophic factor and nerve growth factor mRNA in primary cultures of hippocampal neurons and astrocytes. J Neurosci12: 4793-4799.
29. Song XY, Li F, Zhang FH, Zhong JH, Zhou XF, (2008) Peripherally-derived BDNF promotes regeneration of ascending sensory neurons after spinal cord injury. PLoS One. 3(3): e1707.
30. Schmidt HD, Duman RS, (2010) Peripheral BDNF produces antidepressant-like effects in cellular and behavioral models. Neuropsychopharmacology. 35(12): 2378-91.
31. Sakane T, Pardridge WM, (1997) Carboxyl-directed pegylation of brain-derived neurotrophic factor markedly reduces systemic clearance with minimal loss of biologic activity. Pharm Res. 14: 1085-1091.
32. Pan W, Kastin AJ (1999) Penetration of neurotrophins and cytokines across the blood-brain/blood-spinal cord barrier Advanced Drug Delivery Reviews 36 291-298.
33. Fusco FR, Anzilotti S, Giampà C, Dato C, Laurenti D, et al. (2012) Changes in the expressionoof extracellular regulated kinase (ERK 1/2) in the R6/2 mouse model of Huntington's disease after phosphodiesterase 4 inhibition. Neurobiol. Of Disease 46: 225-233.
34. Giralt A, Carretón O, Lao-Peregrin C, Martín ED, Alberch J, (2011) Conditional BDNF release under pathological conditions improves Huntington's disease pathology by delaying neuronal dysfunction. Mol Neurodegener 6(1): 71.
35. DeMarch Z, Giampa C, Patassini S, Martorana A, Bernardi G, et al. (2008) Beneficial effects of rolipram in a quinolinic acid model of striatal excitotoxicity. Neurobiol Dis25: 266-273.
36. DeMarch Z, Giampà C, Patassini S, Martorana A, Bernardi G, et al. (2007) Beneficial effects of Rolipram in Quinolic acid model of Huntington's Disease. Neurobiology of Disease 25(2): 266-73.
37. Giampà C, Middei S, Patassini S, Borreca A, Marullo F, et al. (2009) Phosphodiesterase type IV inhibition prevents sequestration of CREB binding protein, protects striatal parvalbumin interneurons and rescues motor deficits in the R6/2 mouse model of Huntington's disease. Eur J Neurosci. 29(5): 902-10.
38. Giampà C, Laurenti D, Anzilotti S, Bernardi G, Menniti FS, et al. (2011) Inhibition of the striatal specific phosphodiesterase PDE10A ameliorates striatal and cortical pathology in R6/2 mouse model of Huntington's disease. PLoS One. 5 (10): e13417.
39. Van Rossum D, Hanisch UK, (2004) Microglia. Metab Brain Dis 19: 393-411.
40. Ransohoff RM, Perry VH, (2009) Microglial physiology: unique stimuli, specialized responses. Annu Rev Immunol 27: 119-145.
41. Harry GJ, Kraft AD, (2008) Neuroinflammation and microglia: considerations and approaches for neurotoxicity assessment. Expert Opin Drug Metab Toxicol 4: 1265-1277.
42. Möller T, (2010) Neuroinflammation in Huntington's disease. J Neural Transm. 117(8): 1001-8.
43. Möller T, Weinstein JR, Hanisch UK, (2006) Activation of microglial cells by thrombin: past, present, and future. Semin Thromb Hemost. Apr 32Suppl 1: 69-76.
44. Carlezon WA Jr, Duman RS, Nestler EJ, (2005) The many faces of CREB. Trends Neurosci. 28(8): 436-45.
45. Schmidt HD, Banasr M, Duman RS, (2008) Future antidepressant targets: neurotrophic factors and related signaling cascades. Drug Discov Today Ther Strateg 5: 151-156.
46. Patapoutian A, Reichardt LF (2001) Trk receptors: mediators of neurotrophin action Current Opinion in Neurobiology 11, 3, 272-280.
47. Lonze BE, Ginty DD, (2002) Function and regulation of CREB family transcription factors in the nervous system. Neuron. Aug 15 35(4): 605-23.
48. Kishino A, Katayama N, Ishige Y, Yamamoto Y, Ogo H, et al. (2001) Analysis of effects and pharmacokinetics of subcutaneously administered BDNF NeuroReport, 12, 1067-1072.
49. Pardidge, WM Kang, YS Buciak JL, (1994) Transport of human recombinant brain- derived neurotrophic factor (BDNF) through the rat blood-brain barrier in vivo using vector- mediated peptide drug delivery, Pharm. Res. 11: 738-746.
50. Poduslo JF, Curran GL, (1996) Permeability at the blood-brain and blood-nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF. Brain Res Mol Brain Res. Mar 36(2): 280-6.
51. Givalois L, Naert G, Tapia-Arancibia L, Aranciabia S (2006) Involvement of brain derived neurotrophic factor in the regulation of hypothalamic somatostatin in vivo Journal of Endocrinology 188, 425-433.
52. Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, et al. (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell87: 493-506.
53. Giampa C, DeMarch Z, D'Angelo V, Morello M, Martorana A, et al. (2006) Striatal modulation of cAMP-response-element-binding protein (CREB) after excitotoxic lesions: implications with neuronal vulnerability in Huntington's disease. Eur J Neurosci23: 11-20.
54. Giampà C, Laurenti D, Anzilotti S, Bernardi G, Menniti FS, et al. (2010) Inhibition of the striatal specific phosphodiesterase PDE10A ameliorates striatal and cortical pathology in R6/2 mouse model of huntington's disease. PlosOne 5(10) e13417.
55. Fusco FR, Zuccato C, Tartari M, Martorana A, De March Z, et al. (2003) Co-localization of brain-derived neurotrophic factor (BDNF) and wild-type huntingtin in normal and quinolinic acid-lesioned rat brain. Eur J Neurosci18: 1093-1102.
56. Fusco FR, Chen Q, Lamoreaux WJ, Figueredo-Cardenas G, Jiao Y, et al. (1999) Cellular localization of huntingtin in striatal and cortical neurons in rats: lack of correlation with neuronal vulnerability in Huntington's disease. J Neurosci19: 1189-1202.
57. Meade CA, Deng YP, Fusco FR, Del Mar N, Hersch S, et al. (2002) Cellular localization and development of neuronal intranuclear inclusions in striatal and cortical neurons in R6/2 transgenic mice. J Comp Neurol449: 241-269.
58. Jiao Y, Sun Z, Lee T, Fusco FR, Kimble TD, et al. (1999) A simple and sensitive antigen retrieval method for free-floating and slide-mounted tissue sections. Neurosci Methods. Nov 15 93(2): 149-62.